Brian V. Broberg

Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study

René S. Kahn, Inge Winter van Rossum, Stefan Leucht et al. · The Lancet Psychiatry · 2018 · 190 citations

First-episode Schizophrenia, Psychiatry, Psychotic Disorder +11

Improvement of Brain Reward Abnormalities by Antipsychotic Monotherapy in Schizophrenia

Mette Ødegaard Nielsen, Egill Rostrup, Sanne Wulff et al. · Archives of General Psychiatry · 2012 · 153 citations

Psychotherapy, Neuropsychology, Psychotropic Medication +17

Response to initial antipsychotic treatment in first episode psychosis is related to anterior cingulate glutamate levels: a multicentre 1H-MRS study (OPTiMiSE)

Alice Egerton, Brian V. Broberg, Neeltje E.M. van Haren et al. · Molecular Psychiatry · 2018 · 131 citations · Full text

Psychiatry, Psychotic Disorder, Psychotropic Medication +13

Effect of <scp>GLP</scp> ‐1 receptor agonist treatment on body weight in obese antipsychotic‐treated patients with schizophrenia: <scp>a</scp> randomized, placebo‐controlled trial

Pelle L. Ishøy, Filip K. Knop, Brian V. Broberg et al. · Diabetes Obesity and Metabolism · 2016 · 82 citations · Full text

Towards Precision Medicine in Psychosis: Benefits and Challenges of Multimodal Multicenter Studies—PSYSCAN: Translating Neuroimaging Findings From Research into Clinical Practice

Stefania Tognin, Hendrika H. van Hell, Kate Merritt et al. · Schizophrenia Bulletin · 2019 · 77 citations · Full text

Multimodal Multicenter Studies—psyscan, Psychosis Onset, Neurophysiological Biomarkers +21